Overview / Abstract: |
George Karam, MD reviews a HAP/VAP patient case presented along with a faculty panel at MAD-ID 2019. Discussion topics include challenges with P. aeruginosa, ensuring effectiveness of antibiotics while reducing resistance, as well as new and emerging approaches to Gram-negative organisms. The purpose of this activity is to provide clinicians who care for patients with serious infections with the latest data on antimicrobial stewardship, available and emerging antibiotics against Gram-negative pathogens, and the optimization of therapy to improve outcomes and reduce resistance. Upon completion of this activity, participants will be able to: |
Expiration |
Jun 28, 2020 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Respiratory Therapy CE |
Format |
Online, Podcast, Webinar / Webcast / Video |
Credits / Hours |
0.5 |
Accreditation |
ACCME, ACPE, IACET |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
George H. Karam, MD Jason M. Pogue, PharmD, BCPS‐ID Patricia (Trish) Simner, PhD, D(ABMM) James Lewis, II, PharmD, FIDSA |
Activity Specialities / Related Topics |
Adverse Drug Reactions / ADR, Antibiotics / Anti-Infectives, Contamination & Infection Control, Diagnosis / Assessment / Patient History, Education / Teaching, Hospital-Acquired Infections, Immunology / Immunosuppression, Infectious Disease, Pulmonary Medicine / COPD |
Sponsors / Supporters / Grant Providers |
Sponsored by the Academy for Continued Healthcare Learning (ACHL). Supported by an educational grant from Merck & Company. |
Keywords / Search Terms |
ACHL P. aeruginosa, HAP/VAP, infectious disease, Gram-negative, Karam, Simner, Pogue, Lewis, MAD-ID, MAD, pharmacy, antibiotics, resistance, susceptibility, case presentation, COPD, Merck, ACHL Free CE CME Live CE CME |